ASP

ASP Isotopes

Stock
Stock
Ticker: ASPI
ASPI

Price

Price

CHART BY

Frequently asked questions

What is ASP Isotopes's market capitalization?

The market capitalization of ASP Isotopes is $979.53M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for ASP Isotopes?

ASP Isotopes's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$2.071. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for ASP Isotopes's stock?

Currently, 3 analysts cover ASP Isotopes's stock, with a consensus target price of $13.00. Analyst ratings provide insights into the stock's expected performance.

What is ASP Isotopes's revenue over the trailing twelve months?

Over the trailing twelve months, ASP Isotopes reported a revenue of $26.93M.

What is the EBITDA for ASP Isotopes?

ASP Isotopes's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$68.99M. EBITDA measures the company's overall financial performance.

What is the free cash flow of ASP Isotopes?

ASP Isotopes has a free cash flow of -$65.80M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does ASP Isotopes have, and what sector and industry does it belong to?

ASP Isotopes employs approximately 271 people. It operates in the Industrials sector, specifically within the Major Pharmaceuticals industry.

What is the free float of ASP Isotopes's shares?

The free float of ASP Isotopes is 112.95M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$979.53M
EPS (TTM) 
-$2.071
Free Float 
112.95M
Revenue (TTM) 
$26.93M
EBITDA (TTM) 
-$68.99M
Free Cashflow (TTM) 
-$65.80M

Pricing

1D span
$7.944$8.093
52W span
$3.93$14.48

Analyst Ratings

The price target is $13.00 and the stock is covered by 3 analysts.

Buy

3

Hold

0

Sell

0

Information

ASP Isotopes, Inc. is developing a differentiated isotope enrichment platform to strengthen global supply chain access to critical materials used in nuclear medicine, next-generation semiconductors, and nuclear energy. It operates through the following segments: Nuclear Fuels, Specialist Isotopes and Related Services, and Helium and LNG. The Nuclear Fuels segment engages in the research and development of technologies and methods for producing HALEU and Lithium-6 for the advanced nuclear fuels target market, including the operations of QLE. The Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods for the separation of high-value, low-volume isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Dallas, TX.

Employees
271
Industries
Major Pharmaceuticals
Sector
Industrials

Identifier

Primary Ticker
ASPI

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation